- Home
- Publications
- Publication Search
- Publication Details
Title
STATs in NK-Cells: The Good, the Bad, and the Ugly
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-01-18
DOI
10.3389/fimmu.2016.00694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STAT4-associated natural killer cell tolerance following liver transplantation
- (2016) K M Jamil et al. GUT
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
- (2016) Alessia Bottos et al. Nature Communications
- STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
- (2016) D. Gotthardt et al. Cancer Discovery
- Regulation of Natural Killer Cell Function by STAT3
- (2016) Nicholas A. Cacalano Frontiers in Immunology
- Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity
- (2016) Eva Maria Putz et al. OncoImmunology
- JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
- (2015) Kathrin Schönberg et al. CANCER RESEARCH
- JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
- (2015) L. Springuel et al. HAEMATOLOGICA
- Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
- (2015) M. Hejazi et al. HAEMATOLOGICA
- Long-Term Follow-up of STAT5B Deficiency in Three Argentinian Patients: Clinical and Immunological Features
- (2015) Liliana Bezrodnik et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
- (2015) Alexandra Y. Kreins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of tumor infiltrating natural killer cell subset
- (2015) Inbar Levi et al. Oncotarget
- JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
- (2015) L. Springuel et al. HAEMATOLOGICA
- Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
- (2015) M. Hejazi et al. HAEMATOLOGICA
- In vivotumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
- (2015) Michaela Prchal-Murphy et al. OncoImmunology
- Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
- (2015) Angelika Berger et al. Oncotarget
- The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
- (2015) Antonino Bruno et al. NEOPLASIA
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation
- (2014) S. Zhu et al. BLOOD
- Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
- (2014) D. Gotthardt et al. BLOOD
- Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
- (2014) D. Mittal et al. CANCER RESEARCH
- IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness
- (2014) Andrea Ziblat et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Inborn errors of the development of human natural killer cells
- (2013) Emmanuelle Jouanguy et al. Current Opinion in Allergy and Clinical Immunology
- T cell regulation of natural killer cells
- (2013) Yann Kerdiles et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
- (2013) C. Fionda et al. JOURNAL OF IMMUNOLOGY
- CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
- (2013) Eva Maria Putz et al. Cell Reports
- Epigenetic regulation of NK cell differentiation and effector functions
- (2013) Frank Cichocki et al. Frontiers in Immunology
- Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes
- (2012) Stephanie Boisson-Dupuis et al. CURRENT OPINION IN IMMUNOLOGY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Proinflammatory cytokine signaling required for the generation of natural killer cell memory
- (2012) Joseph C. Sun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
- (2012) Rupsha Fraser et al. JOURNAL OF PATHOLOGY
- Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
- (2012) Tatsuaki Mizutani et al. OncoImmunology
- Severe impairment of IFN- and IFN- responses in cells of a patient with a novel STAT1 splicing mutation
- (2011) D. Vairo et al. BLOOD
- Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
- (2011) R. Bedel et al. CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
- (2011) Alice Laroni et al. PLoS One
- Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions
- (2011) D. Chakraborty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
- (2010) E. Eckelhart et al. BLOOD
- Natural Killer Cell Education and Tolerance
- (2010) Mark T. Orr et al. CELL
- IL-7 Enhances Survival of Human CD56bright NK Cells
- (2010) Annie Michaud et al. JOURNAL OF IMMUNOTHERAPY
- Tumor-associated macrophages: Effectors of angiogenesis and tumor progression
- (2009) Seth B. Coffelt et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
- (2009) M. Matsui et al. CANCER RESEARCH
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease
- (2009) Zhanju Liu et al. INFLAMMATORY BOWEL DISEASES
- A partial form of recessive STAT1 deficiency in humans
- (2009) Ariane Chapgier et al. JOURNAL OF CLINICAL INVESTIGATION
- A Programmed Switch from IL-15- to IL-2-Dependent Activation in Human NK Cells
- (2009) Anne-Hélène Pillet et al. JOURNAL OF IMMUNOLOGY
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells
- (2008) L R Grant et al. GENES AND IMMUNITY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Canonical and non-canonical JAK–STAT signaling
- (2008) Willis X. Li TRENDS IN CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search